Overview of the Management of COVID-19 Efficacy and Doubts
O. A. Ayodeji
Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital (UPTH), Port Harcourt, Nigeria.
C. N. Stanley
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Nigeria.
P. C. Stanley *
Department of Neuropsychiatry, University of Port Harcourt Teaching Hospital (UPTH), Port Harcourt, Nigeria.
*Author to whom correspondence should be addressed.
Abstract
Coronavirus disease 2019 (COVID-19) is defined as an illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2. It was first identified during an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China. Management of COVID-19 is still unspecific as there are no vaccine or specific antiviral drugs are available for its treatment. This paper reviews the management efficacy and doubt of COVID-19.
Methods: A comprehensive search from relevant literatures, World Health Organization (W.H.O), Centre for Disease Control and prevention (CDC) official websites and announcements was performed between 1 March 2020 to 10:30 am 22 April 2020 (Nigerian time). A latest summary of 2019- nCoV and the current outbreak was drawn.
Conclusion: The covid-19 pandemic is spreading rapidly and several researchers are making efforts to discover drugs for its treatment. Chloroquine phosphate, vaccines and other forms of management strategies have been employed. However, preventive measures like social distancing, washing of hands with soap and water, wearing of face masks and psychosocial treatment should be adopted while waiting for pharmacological treatments.
Keywords: Middle East respiratory syndrome coronavirus, SARS-CoV-2, antiviral therapy, coronavirus disease 2019 (COVID-19), coronavirus vaccines, severe acute respiratory syndrome coronavirus (SARS-CoV).